Can stuffed animals, rose petals, and injections of an Elon Musk–approved dissociative drug help Silicon Valley leaders out ...
Twice-yearly lenacapavir PrEP could be available as early as this summer pending federal Food and Drug Administration ...
Vincent Gaynor remembers, almost to the minute, when he realized his part in birthing the breakthrough gene therapy Zolgensma ...
The biosimilars reach the US market as the US insulin space has seen seismic changes in the last few years, with a clamour of ...
6d
GlobalData on MSNGalderma enters fierce European atopic dermatitis market with Nemluvio approvalNemluvio, which was also approved for prurigo nodularis, becomes Galderma’s first approved biologic in its dermatology ...
The US carried out a double state killing on Thursday, with two states executing intellectually disabled death row inmates.
Live updates from SNL’s anniversary special, which marks 50 years since Lorne Michaels created “Saturday Night Live.” ...
Ionis relies on upfront payments and licensing fees from partners, as well as Spinraza royalties, to drive revenue today, but its rapidly advancing portfolio should help diversify revenue. 2025 is ...
Nemluvio is now the first approved monoclonal antibody that specifically targets interleukin-31 receptor alpha ...
Nigeria’s storage infrastructure crisis presents an opportunity worth as much as N160 billion in market valuation for daring ...
Eli Lilly 's blockbuster weight loss drugs, and questions about its valuation. Then, Ricky continues his conversation with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results